Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cytoplasmic polyadenylation element-binding protein 4
(
CPEB4
) is a highly conserved, sequence-specific RNA-binding protein that recruits translational repression or cytoplasmic polyadenylation machinery to target mRNAs. Recent studies have shown that CPEBs are expressed in somatic tissues and have essential functions supporting tumor growth, vascularization, and invasion. Overexpression of
CPEB4
has been reported in pancreatic ductal adenocarcinoma and is associated with poor prognoses. However, whether
CPEB4
plays a role in the tumorigenesis of gliomas is unknown. Here, we analyzed the expression of
CPEB4
in gliomas. The expression profiles of
CPEB4
mRNA and protein in nine normal brain tissues and 63 gliomas were detected using immunohistochemistry, real-time PCR, and western blotting.
CPEB4
-positive expression was significantly correlated with the pathological grade of
glioma
; abundant expression was observed in high-grade gliomas, whereas little or no expression was observed in normal astrocytes. Immunohistochemistry staining indicated that
CPEB4
was mainly localized in the cytoplasm. In addition,
CPEB4
was more highly expressed in U87
glioma
cells than in U251 cells.
CPEB4
expression significantly correlated with the grade in clinical gliomas. This study suggested that
CPEB4
might play a role in the pathogenesis of
glioma
.
...
PMID:Cytoplasmic polyadenylation element-binding protein 4 is highly expressed in human glioma. 2709 14